Executive Debrief

The Debrief offers concise updates on China's evolving access landscape for innovative medicines to senior-level decision-makers and global teams. It distills trends, strives for a balanced perspective on opportunities and challenges, and helps global teams connect the dots as they develop China-tailored strategies and plans.

Apr

NRDL+ 2025 Annual Executive Debrief: The State of Access for Innovative Medicines in China

This Access360 Executive Briefing lays the groundwork for understanding China’s shift toward value-based pricing, deeper insurance–medicine–care integration, and broader market transformation driven by its national commercial insurance catalog initiatives.

Apr 30, 2025

1 min read

Apr

NRDL+ 2024 Annual Executive Debrief: The State of Access for Innovative Medicines in China

Back to Access360 In this inaugural annual NRDL+ debrief, we comprehensively examined pivotal developments and trends across basic medical insurance

Apr 11, 2024

1 min read